215 related articles for article (PubMed ID: 18619921)
1. Increased immune reactivity predicts aggressive complicating Crohn's disease in children.
Dubinsky MC; Kugathasan S; Mei L; Picornell Y; Nebel J; Wrobel I; Quiros A; Silber G; Wahbeh G; Katzir L; Vasiliauskas E; Bahar R; Otley A; Mack D; Evans J; Rosh J; Hemker MO; Leleiko N; Crandall W; Langton C; Landers C; Taylor KD; Targan SR; Rotter JI; Markowitz J; Hyams J; ; ;
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1105-11. PubMed ID: 18619921
[TBL] [Abstract][Full Text] [Related]
2. Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression.
Dubinsky MC; Lin YC; Dutridge D; Picornell Y; Landers CJ; Farrior S; Wrobel I; Quiros A; Vasiliauskas EA; Grill B; Israel D; Bahar R; Christie D; Wahbeh G; Silber G; Dallazadeh S; Shah P; Thomas D; Kelts D; Hershberg RM; Elson CO; Targan SR; Taylor KD; Rotter JI; Yang H;
Am J Gastroenterol; 2006 Feb; 101(2):360-7. PubMed ID: 16454844
[TBL] [Abstract][Full Text] [Related]
3. Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.
Papadakis KA; Yang H; Ippoliti A; Mei L; Elson CO; Hershberg RM; Vasiliauskas EA; Fleshner PR; Abreu MT; Taylor K; Landers CJ; Rotter JI; Targan SR
Inflamm Bowel Dis; 2007 May; 13(5):524-30. PubMed ID: 17260364
[TBL] [Abstract][Full Text] [Related]
4. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in Crohn's disease.
Murdoch TB; Xu W; Stempak JM; Landers C; Targan SR; Rotter JI; Silverberg MS
Inflamm Bowel Dis; 2012 Sep; 18(9):1743-8. PubMed ID: 22275320
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort.
Schoepfer AM; Schaffer T; Mueller S; Flogerzi B; Vassella E; Seibold-Schmid B; Seibold F
Inflamm Bowel Dis; 2009 Sep; 15(9):1358-67. PubMed ID: 19253375
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease.
Dassopoulos T; Frangakis C; Cruz-Correa M; Talor MV; Burek CL; Datta L; Nouvet F; Bayless TM; Brant SR
Inflamm Bowel Dis; 2007 Feb; 13(2):143-51. PubMed ID: 17206688
[TBL] [Abstract][Full Text] [Related]
7. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL
Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
[TBL] [Abstract][Full Text] [Related]
8. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.
Targan SR; Landers CJ; Yang H; Lodes MJ; Cong Y; Papadakis KA; Vasiliauskas E; Elson CO; Hershberg RM
Gastroenterology; 2005 Jun; 128(7):2020-8. PubMed ID: 15940634
[TBL] [Abstract][Full Text] [Related]
10. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
Arnott ID; Landers CJ; Nimmo EJ; Drummond HE; Smith BK; Targan SR; Satsangi J
Am J Gastroenterol; 2004 Dec; 99(12):2376-84. PubMed ID: 15571586
[TBL] [Abstract][Full Text] [Related]
11. [Possible pathogenic role of vascular, immunologic and genetic factors in certain gastroenterologic disorders].
Papp M
Orv Hetil; 2008 Nov; 149(48):2269-76. PubMed ID: 19028649
[TBL] [Abstract][Full Text] [Related]
12. [Relevance of serologic studies in inflammatory bowel diseases].
Papp M; Altorjay I; Lakatos PL
Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
[TBL] [Abstract][Full Text] [Related]
13. CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients.
Cruyssen BV; Peeters H; Hoffman IE; Laukens D; Coucke P; Marichal D; Cuvelier C; Remaut E; Veys EM; Mielants H; De Vos M; De Keyser F
Clin Exp Immunol; 2005 May; 140(2):354-9. PubMed ID: 15807862
[TBL] [Abstract][Full Text] [Related]
14. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR
Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777
[TBL] [Abstract][Full Text] [Related]
15. Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn' s disease population.
Linskens RK; Mallant-Hent RC; Murillo LS; von Blomberg BM; Alizadeh BZ; Peña AS
Dig Liver Dis; 2004 Jan; 36(1):29-34. PubMed ID: 14971813
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
Kim BG; Kim YS; Kim JS; Jung HC; Song IS
Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
[TBL] [Abstract][Full Text] [Related]
17. Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort.
Ryan JD; Silverberg MS; Xu W; Graff LA; Targownik LE; Walker JR; Carr R; Clara I; Miller N; Rogala L; Bernstein CN
Aliment Pharmacol Ther; 2013 Aug; 38(3):274-83. PubMed ID: 23725363
[TBL] [Abstract][Full Text] [Related]
18. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
19. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.
Devlin SM; Yang H; Ippoliti A; Taylor KD; Landers CJ; Su X; Abreu MT; Papadakis KA; Vasiliauskas EA; Melmed GY; Fleshner PR; Mei L; Rotter JI; Targan SR
Gastroenterology; 2007 Feb; 132(2):576-86. PubMed ID: 17258734
[TBL] [Abstract][Full Text] [Related]
20. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
Torres J; Petralia F; Sato T; Wang P; Telesco SE; Choung RS; Strauss R; Li XJ; Laird RM; Gutierrez RL; Porter CK; Plevy S; Princen F; Murray JA; Riddle MS; Colombel JF
Gastroenterology; 2020 Jul; 159(1):96-104. PubMed ID: 32165208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
